SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
143 hedge funds and large institutions have $927M invested in Sage Therapeutics in 2016 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 72 increasing their positions, 27 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% more funds holding
Funds holding: 137 → 143 (+6)
32% less capital invested
Capital invested by funds: $1.37B → $927M (-$440M)
Holders
143
Holding in Top 10
10
Calls
$3.63M
Puts
$2.12M
Top Buyers
| 1 | +$24M | |
| 2 | +$20.2M | |
| 3 | +$16.5M | |
| 4 |
VAM
Visium Asset Management
New York
|
+$15.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.1M |
Top Sellers
| 1 | -$18.1M | |
| 2 | -$8.92M | |
| 3 | -$7.01M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$6.75M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$5.16M |